CA2562992C - Analogues du probucol et leur utilisation en tant qu'inhibiteurs anti-inflammatoires de vcam-1 - Google Patents

Analogues du probucol et leur utilisation en tant qu'inhibiteurs anti-inflammatoires de vcam-1 Download PDF

Info

Publication number
CA2562992C
CA2562992C CA2562992A CA2562992A CA2562992C CA 2562992 C CA2562992 C CA 2562992C CA 2562992 A CA2562992 A CA 2562992A CA 2562992 A CA2562992 A CA 2562992A CA 2562992 C CA2562992 C CA 2562992C
Authority
CA
Canada
Prior art keywords
butyl
compound
disease
alkyl
thio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2562992A
Other languages
English (en)
Other versions
CA2562992A1 (fr
Inventor
Patricia K. Somers
Lee K. Hoong
Charles Q. Meng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atherogenics Inc
Original Assignee
Atherogenics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atherogenics Inc filed Critical Atherogenics Inc
Priority claimed from CA002289851A external-priority patent/CA2289851C/fr
Publication of CA2562992A1 publication Critical patent/CA2562992A1/fr
Application granted granted Critical
Publication of CA2562992C publication Critical patent/CA2562992C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2562992A 1997-05-14 1998-05-14 Analogues du probucol et leur utilisation en tant qu'inhibiteurs anti-inflammatoires de vcam-1 Expired - Fee Related CA2562992C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4702097P 1997-05-14 1997-05-14
US60/047,020 1997-05-14
CA002289851A CA2289851C (fr) 1997-05-14 1998-05-14 Composes et methodes d'inhibition de l'expression de vcam-1

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002289851A Division CA2289851C (fr) 1997-05-14 1998-05-14 Composes et methodes d'inhibition de l'expression de vcam-1

Publications (2)

Publication Number Publication Date
CA2562992A1 CA2562992A1 (fr) 1998-11-19
CA2562992C true CA2562992C (fr) 2010-09-28

Family

ID=37682471

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2562992A Expired - Fee Related CA2562992C (fr) 1997-05-14 1998-05-14 Analogues du probucol et leur utilisation en tant qu'inhibiteurs anti-inflammatoires de vcam-1

Country Status (1)

Country Link
CA (1) CA2562992C (fr)

Also Published As

Publication number Publication date
CA2562992A1 (fr) 1998-11-19

Similar Documents

Publication Publication Date Title
CA2289851C (fr) Composes et methodes d'inhibition de l'expression de vcam-1
CA2562992C (fr) Analogues du probucol et leur utilisation en tant qu'inhibiteurs anti-inflammatoires de vcam-1
AU2002300328B2 (en) Compounds and methods for the inhibition of the expression of VCAM-1
AU2006202461B2 (en) Compositions and methods for the inhibition of the expression of VCAM-1
EP1464639A1 (fr) Ester de l'acide succinique du probucol pour l'inhibition de l'expression de VCAM-1
EP1726582A2 (fr) Composés et méthodes d'inhibition de l'expression de VCAM-1
EP1695959A1 (fr) Composes et methodes d'inhibition de l'expression de VCAM-1
MXPA99010402A (en) Compounds and methods for the inhibition of the expression of vcam-1

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed